| Literature DB >> 21602043 |
Jan Kehler1, Andreas Ritzen, Morten Langgård, Sebastian Leth Petersen, Mohamed M Farah, Christoffer Bundgaard, Claus Tornby Christoffersen, Jacob Nielsen, John Paul Kilburn.
Abstract
Novel triazoloquinazolines have been found as phosphodiesterase 10A (PDE10A) inhibitors. Structure-activity studies improved the initial micromolar potency which was found in the lead compound by a 100-fold identifying 5-(1H-benzoimidazol-2-ylmethylsulfanyl)-2-methyl-[1,2,4]triazolo[1,5-c]quinazoline, 42 (PDE10A IC(50)=12 nM) as the most potent compound from the series. Two X-ray structures revealed novel binding modes to the catalytic site of the PDE10A enzyme.Entities:
Mesh:
Substances:
Year: 2011 PMID: 21602043 DOI: 10.1016/j.bmcl.2011.04.067
Source DB: PubMed Journal: Bioorg Med Chem Lett ISSN: 0960-894X Impact factor: 2.823